Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity

Rheumatology (Oxford). 2021 Jul 1;60(7):e270-e271. doi: 10.1093/rheumatology/kez608.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers
  • Fluorodeoxyglucose F18
  • Humans
  • Muscles
  • Myositis* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography*
  • Positron-Emission Tomography

Substances

  • Biomarkers
  • Fluorodeoxyglucose F18